Daniel G. Anderson
Cited by
Cited by
Knocking down barriers: advances in siRNA delivery
KA Whitehead, R Langer, DG Anderson
Nature reviews Drug discovery 8 (2), 129-138, 2009
Non-viral vectors for gene-based therapy
H Yin, RL Kanasty, AA Eltoukhy, AJ Vegas, JR Dorkin, DG Anderson
Nature reviews genetics 15 (8), 541-555, 2014
Physical and mechanical properties of PLA, and their functions in widespread applications—A comprehensive review
S Farah, DG Anderson, R Langer
Advanced drug delivery reviews 107, 367-392, 2016
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised …
B Burtness, KJ Harrington, R Greil, D Soulières, M Tahara, G de Castro, ...
The Lancet 394 (10212), 1915-1928, 2019
Delivery materials for siRNA therapeutics
R Kanasty, JR Dorkin, A Vegas, D Anderson
Nature materials 12 (11), 967-977, 2013
CRISPR-Cas9 knockin mice for genome editing and cancer modeling
RJ Platt, S Chen, Y Zhou, MJ Yim, L Swiech, HR Kempton, JE Dahlman, ...
Cell 159 (2), 440-455, 2014
A combinatorial library of lipid-like materials for delivery of RNAi therapeutics
A Akinc, A Zumbuehl, M Goldberg, ES Leshchiner, V Busini, N Hossain, ...
Nature biotechnology 26 (5), 561-569, 2008
Treating metastatic cancer with nanotechnology
A Schroeder, DA Heller, MM Winslow, JE Dahlman, GW Pratt, R Langer, ...
Nature Reviews Cancer 12 (1), 39-50, 2012
Molecularly self-assembled nucleic acid nanoparticles for targeted in vivo siRNA delivery
H Lee, AKR Lytton-Jean, Y Chen, KT Love, AI Park, ED Karagiannis, ...
Nature nanotechnology 7 (6), 389-393, 2012
Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype
H Yin, W Xue, S Chen, RL Bogorad, E Benedetti, M Grompe, ...
Nature biotechnology 32 (6), 551-553, 2014
Lipid-like materials for low-dose, in vivo gene silencing
KT Love, KP Mahon, CG Levins, KA Whitehead, W Querbes, JR Dorkin, ...
Proceedings of the National Academy of Sciences 107 (5), 1864-1869, 2010
Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo
H Yin, CQ Song, JR Dorkin, LJ Zhu, Y Li, Q Wu, A Park, J Yang, S Suresh, ...
Nature biotechnology 34 (3), 328-333, 2016
Nanoliter-scale synthesis of arrayed biomaterials and application to human embryonic stem cells
DG Anderson, S Levenberg, R Langer
Nature biotechnology 22 (7), 863-866, 2004
CRISPR-mediated direct mutation of cancer genes in the mouse liver
W Xue, S Chen, H Yin, T Tammela, T Papagiannakopoulos, NS Joshi, ...
Nature 514 (7522), 380-384, 2014
Therapeutic siRNA silencing in inflammatory monocytes in mice
F Leuschner, P Dutta, R Gorbatov, TI Novobrantseva, JS Donahoe, ...
Nature biotechnology 29 (11), 1005-1010, 2011
Delivering the messenger: advances in technologies for therapeutic mRNA delivery
PS Kowalski, A Rudra, L Miao, DG Anderson
Molecular Therapy 27 (4), 710-728, 2019
Size-and shape-dependent foreign body immune response to materials implanted in rodents and non-human primates
O Veiseh, JC Doloff, M Ma, AJ Vegas, HH Tam, AR Bader, J Li, E Langan, ...
Nature materials 14 (6), 643-651, 2015
Efficiency of siRNA delivery by lipid nanoparticles is limited by endocytic recycling
G Sahay, W Querbes, C Alabi, A Eltoukhy, S Sarkar, C Zurenko, ...
Nature biotechnology 31 (7), 653-658, 2013
Bio-inspired polymer composite actuator and generator driven by water gradients
M Ma, L Guo, DG Anderson, R Langer
Science 339 (6116), 186-189, 2013
Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates
M Frank-Kamenetsky, A Grefhorst, NN Anderson, TS Racie, B Bramlage, ...
Proceedings of the National Academy of Sciences 105 (33), 11915-11920, 2008
The system can't perform the operation now. Try again later.
Articles 1–20